Narodowy Instytut Onkologii im. Marii Skłodowskiej-Curie – Państwowy Instytut Badawczy, do 2020 Centrum Onkologii – Instytut im. Marii Skłodowskiej-Curie – placówka onkologiczna i państwowy instytut badawczy. Wywodzi się z Instytutu Radowego, założonego w 1932 roku z inicjatywy Marii Skłodowskiej-Curie.

During the past decade, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology conducted 19 clinical trials. In the 10-year time frame, 19 clinical trials started and 4 clinical trials were completed, i.e. on average, 21.1% percent of trials that started reached the finish line to date. In the past 5 years, 12 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology" #1 sponsor was "European Organisation for Research and Treatment of Cancer - EORTC" with 22 trials, followed by "Maria Sklodowska-Curie National Research Institute of Oncology" with 11 trials sponsored, "European Mantle Cell Lymphoma Network" with 2 trials sponsored, "Fondazione IRCCS Istituto Nazionale dei Tumori, Milano" with 2 trials sponsored and "Incyte Corporation" with 2 trials sponsored. Other sponsors include 16 different institutions and companies that sponsored additional 25 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology" #1 collaborator was "European Organisation for Research and Treatment of Cancer - EORTC" with 4 trials as a collaborator, "Lymphoma Study Association" with 4 trials as a collaborator, "NCIC Clinical Trials Group" with 4 trials as a collaborator, "Centre of Postgraduate Medical Education" with 3 trials as a collaborator and "Lymphoma Trials Office" with 3 trials as a collaborator. Other collaborators include 40 different institutions and companies that were collaborators in the rest 44 trials.

According to Clinical.Site data, the most researched conditions in "Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology" are "Breast Cancer" (7 trials), "Lymphoma" (7 trials), "Colorectal Cancer" (5 trials), "Melanoma (Skin)" (4 trials) and "Metastatic Cancer" (4 trials). Many other conditions were trialed in "Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology" in a lesser frequency.

Most popular intervention types in "Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology" are "Drug" (35 trials), "Biological" (18 trials), "Procedure" (14 trials), "Radiation" (12 trials) and "Other" (11 trials). Other intervention types were less common.

The name of intervention was led by "cisplatin" (8 trials), "radiation therapy" (8 trials), "cyclophosphamide" (6 trials), "doxorubicin hydrochloride" (6 trials) and "filgrastim" (6 trials). Other intervention names were less common.

The vast majority of trials in "Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology" are 48 trials for "All" genders, 7 trials for "Female" genders and 5 trials for "Male" genders.

Currently, there are NaN active trials in "Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology". 1 are not yet recruiting, 9 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 26 completed trials in Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, 1 "Phase 1" clinical trials were conducted, 16 "Phase 2" clinical trials and 33 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 5 trials that are defined as “Not Applicable".